124 related articles for article (PubMed ID: 7664900)
1. The prognostic significance of the cytophotometric DNA content and its relationship with the argyrophilic nucleolar organizer regions (AgNOR) and proliferating cell nuclear antigen (PCNA) in oesophageal cancer.
Kuwano H; Sumiyoshi K; Nozoe T; Yasuda M; Watanabe M; Sugimachi K
Eur J Surg Oncol; 1995 Aug; 21(4):368-73. PubMed ID: 7664900
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of argyrophilic nucleolar organizer region and proliferating cell nuclear antigen in colorectal cancer.
Nakae S; Nakamura T; Ikegawa R; Yoshioka H; Shirono J; Tabuchi Y
J Surg Oncol; 1998 Sep; 69(1):28-35. PubMed ID: 9762888
[TBL] [Abstract][Full Text] [Related]
3. Cytophotometric DNA content and argyrophilic nucleolar organiser regions of oesophageal carcinoma.
Morita M; Kuwano H; Tsutsui S; Ohno S; Matsuda H; Sugimachi K
Br J Cancer; 1993 Mar; 67(3):480-5. PubMed ID: 8439498
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of proliferating cell nuclear antigen (PCNA) and argyrophilic nucleolar organizer region (AgNOR) in testicular tumors].
Ohyama C; Ito A; Tokuyama S; Nakazumi H; Suzuki K; Kawamura S; Sato M; Saito S; Yoshikawa K; Hoshi S
Nihon Hinyokika Gakkai Zasshi; 1995 Oct; 86(10):1543-51. PubMed ID: 7474604
[TBL] [Abstract][Full Text] [Related]
5. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
6. PCNA immunostaining combined with AgNOR staining in esophageal squamous cell carcinoma to identify patients with a poor prognosis.
Morisaki Y; Shima S; Yoshizumi Y; Sugiura Y; Tanaka S; Tamai S
Surg Today; 1995; 25(5):389-95. PubMed ID: 7640465
[TBL] [Abstract][Full Text] [Related]
7. Argyrophilic nucleolar organizer regions, bromodeoxyuridine labelling index and DNA ploidy in squamous cell carcinoma of the uterine cervix.
Gasińska A; Zabagło L; Cichocka A; Pudełek J; Urbański K; Skołyszewski J
Folia Histochem Cytobiol; 1996; 34(2):95-101. PubMed ID: 8875218
[TBL] [Abstract][Full Text] [Related]
8. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
[TBL] [Abstract][Full Text] [Related]
9. [Significance of FCM-DNA ploidy pattern, AgNOR counting, hTERT and PCNA expression in differentiating malignant from benign serous effusion].
Wu LY; Liu BR; Lu J; Ling MD; Chen J; Li P; Jiang Y
Ai Zheng; 2007 Feb; 26(2):178-82. PubMed ID: 17298749
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in urachal adenocarcinoma. A study in 41 specimens of DNA status, proliferating cell-nuclear antigen immunostaining, and argyrophilic nucleolar-organizer region counts.
Nakanishi K; Kawai T; Suzuki M; Torikata C
Hum Pathol; 1996 Mar; 27(3):240-7. PubMed ID: 8600037
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.
Ghazizadeh M; Sasaki Y; Araki T; Konishi H; Aihara K
Am J Clin Pathol; 1997 Apr; 107(4):451-8. PubMed ID: 9124214
[TBL] [Abstract][Full Text] [Related]
12. Comparison of silver-staining nucleolar organizer region (AgNOR) counts and proliferating cell nuclear antigen (PCNA) expression in reactive mesothelial hyperplasia and malignant mesothelioma.
Bethwaite PB; Delahunt B; Holloway LJ; Thornton A
Pathology; 1995 Jan; 27(1):1-4. PubMed ID: 7603742
[TBL] [Abstract][Full Text] [Related]
13. Assessment of proliferative activity in Wilms' tumour.
Delahunt B; Farrant GJ; Bethwaite PB; Nacey JN; Lewis ME
Anal Cell Pathol; 1994 Aug; 7(2):127-38. PubMed ID: 7993823
[TBL] [Abstract][Full Text] [Related]
14. Morphometric determination of AgNORs in breast carcinoma. Correlation with flow cytometry and proliferating cell nuclear antigen.
Bellotti M; Elsner B; Kahn A; Bezodnick L; Pisilli L; Greco P
Anal Quant Cytol Histol; 1997 Apr; 19(2):139-44. PubMed ID: 9113306
[TBL] [Abstract][Full Text] [Related]
15. Nucleolar organizer regions and PCNA expression in prostatic cancers.
Kawase N; Shiokawa A; Ota H; Saitoh T; Yoshida H; Kazama K
Pathol Int; 1994 Mar; 44(3):213-22. PubMed ID: 7517763
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of argyrophilic nucleolar organizer regions (AGNOR) in oesophageal cancer.
Babu M; Mathur M; Gupta SD; Chattopadhyay TK
Trop Gastroenterol; 1996; 17(1):57-60. PubMed ID: 8693588
[TBL] [Abstract][Full Text] [Related]
17. The prognostic role of proliferation activity in human CNS tumours: the determination of AgNOR, PCNA and Ki-67 expression. Part 1: AgNOR expression in CNS tumours.
Janczukowicz J
Folia Neuropathol; 2003; 41(2):97-101. PubMed ID: 12899202
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
[TBL] [Abstract][Full Text] [Related]
19. Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections.
Korkolopoulou P; Christodoulou P; Papanikolaou A; Thomas-Tsagli E
Am J Surg Pathol; 1993 Sep; 17(9):912-9. PubMed ID: 8102513
[TBL] [Abstract][Full Text] [Related]
20. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions.
Brustmann H; Naudé S
Gynecol Oncol; 2002 Aug; 86(2):192-9. PubMed ID: 12144828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]